The Efficacy and Safety of Ultrasound-Guided Acupotomy for Post-Stroke Spasticity

The Efficacy and Safety of Ultrasound-Guided Acupotomy for Post-Stroke Equinovarus Foot: A single center, randomized, open-label controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0009924

Enrollment

Registered

2024-11-13

Start date

2025-01-02

Completion date

Unknown

Last updated

2024-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : -Experimental Group: Standard rehabilitation treatment for stroke + ultrasound-guided acupotomy for lower limb spasticity -Control Group: Standard rehabilitation treatment for stro

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Men and women aged 19 years or older 2) Patients diagnosed with stroke (including ischemic stroke, hemorrhagic stroke, and subarachnoid hemorrhage, I60-I63) based on clinical presentation and radiological findings 3) Patients who have had a stroke more than 3 months (90 days) prior 4) Patients with spastic equinovarus foot on the affected lower limb with a Modified Ashworth Scale score of 2 or higher 5) Patients with a Functional Ambulation Category (FAC) of 3 or higher 6) Patients who understand the purpose of the study and voluntarily consent to participate in writing, either by themselves or through their guardian/representative

Exclusion criteria

Exclusion criteria: 1) Patients with traumatic hemorrhagic stroke or traumatic subarachnoid hemorrhage 2) Patients who require bed rest due to unstable vital signs after stroke 3) Patients who have started treatment for spastic equinovarus foot (e.g., botulinum toxin injection, chemical neurolysis, surgical therapy, intrathecal baclofen injection, etc.) within the last 3 months 4) Patients whose spasticity is caused by congenital malformations or bone deformities, rather than stroke 5) Patients taking anticoagulants with an INR of 4.0 or higher 6) Patients with serious bleeding disorders such as hemophilia 7) Patients with signs of infection or other skin conditions at the site of intended acupotomy 8) Patients deemed physically or mentally unsuitable for participation in the study based on clinical judgment

Design outcomes

Primary

Measure	Time frame
step length ratio	—

Secondary

Measure	Time frame
walking velocity;lateral symmetry;95% confidence ellipse area,;COP average velocity;Modified Ashworth Scale	—

Countries

Korea, Republic of

Contacts

Public ContactCheol-Hyun Kim

Wonkwang University, Gwangju Medical Center

user2307@hanmail.net+82-62-670-6412

Outcome results